# Assessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock

> **NCT04964492** · — · UNKNOWN · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 30 (estimated)

## Conditions studied

- Vasoplegia
- Hemodynamics
- Intensive Care Unit
- Shock

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04964492
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-13
- **Primary completion:** 2023-10
- **Final completion:** 2023-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04964492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04964492, "Assessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04964492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*